Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
2031 - 2040 of 9038 Results
Title
Year
  • Year
  • 2012
  • 2012
  • 2012
  • 2012
  • 2013
  • 2012
  • 2014
  • 2014
  • 2014
  • 2015
  • Bid signal pathway components are identified in the temporal cortex with Parkinson disease
    2012
    Summary Details
    OPEN
    Title: Bid signal pathway components are identified in the temporal cortex with Parkinson disease
    Author(s): Hong Jiang, Ping He, Charles H. Adler, Holly A. Shill, Thomas G. Beach, Rena Li, Yong Shen
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 79
    Issue #: 17
    Start Page: 1767
    End Page: 1773
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182703f76
    Best OA location URL: https://n.neurology.org/content/neurology/79/17/1767.full.pdf
    Citation Count: 18
  • Increased PK11195 PET binding in the cortex of patients with MS correlates with disability
    2012
    Summary Details
    OPEN
    Title: Increased PK11195 PET binding in the cortex of patients with MS correlates with disability
    Author(s): Marios Politis, Paolo Giannetti, Paul Su, Federico Turkheimer, Shiva Keihaninejad, Kit Wu, Adam Waldman, Omar Malik, Paul M. Matthews, Richard Reynolds, Richard Nicholas, Paola Piccini
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 79
    Issue #: 6
    Start Page: 523
    End Page: 530
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182635645
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3413767
    Citation Count: 174
  • Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]
    2012
    Summary Details
    OPEN
    Title: Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]
    Author(s): Melissa J. Armstrong, Janis M. Miyasaki
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 79
    Issue #: 6
    Start Page: 597
    End Page: 603
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e318263c443
    Best OA location URL: https://n.neurology.org/content/neurology/79/6/597.full.pdf
    Citation Count: 174
  • Neurologist-associated reduction in PD-related hospitalizations and health care expenditures
    2012
    Summary Details
    OPEN
    Title: Neurologist-associated reduction in PD-related hospitalizations and health care expenditures
    Author(s): Allison W. Willis, Mario Schootman, Rebecca Tran, Nathan H. Kung, Bradley Evanoff, Joel S. Perlmutter, Brad A. Racette
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 79
    Issue #: 17
    Start Page: 1774
    End Page: 1780
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182703f92
    Best OA location URL: https://n.neurology.org/content/neurology/79/17/1774.full.pdf
    Citation Count: 104
  • Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
    2013
    Summary Details
    OPEN
    Title: Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
    Author(s): Raymond T. Bartus, Tiffany Baumann, João Siffert, Christopher D. Herzog, Ron L. Alterman, Nicholas M. Boulis, Dennis A. Turner, Mark Stacy, Anthony E. Lang, Andrés M. Lozano, C. Warren Olanow
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 80
    Issue #: 18
    Start Page: 1698
    End Page: 1701
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182904faa
    Best OA location URL: https://n.neurology.org/content/neurology/80/18/1698.full.pdf
    Citation Count: 211
  • Prospective cohort study of spinal muscular atrophy types 2 and 3
    2012
    Summary Details
    OPEN
    Title: Prospective cohort study of spinal muscular atrophy types 2 and 3
    Author(s): Petra Kaufmann, Michael McDermott, Basil T. Darras, Richard S. Finkel, Douglas M. Sproule, Peter B. Kang, Maryam Oskoui, Andrei Constantinescu, Clifton L. Gooch, A. Reghan Foley, Michele Yang, Rabi Tawil, Wendy K. Chung, William B. Martens, Jacqueline Montes, Vanessa Battista, Jessica O’Hagen, Sally Dunaway Young, Jean Flickinger, Janet Quigley, Susan Riley, Allan M. Glanzman, Maryjane Benton, Patricia Ryan, Mark Punyanitya, Megan J. Montgomery, Jonathan Marra, Benjamin Koo, Darryl C. De Vivo
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 79
    Issue #: 18
    Start Page: 1889
    End Page: 1897
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e318271f7e4
    Best OA location URL: https://n.neurology.org/content/neurology/79/18/1889.full.pdf
    Citation Count: 289
  • Barriers to investigator-initiated deep brain stimulation and device research
    2014
    Summary Details
    OPEN
    Title: Barriers to investigator-initiated deep brain stimulation and device research
    Author(s): Michael L. Kelly, Donald A. Malone, Michael S. Okun, Joan E. Booth, André G. Machado
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 82
    Issue #: 16
    Start Page: 1465
    End Page: 1473
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000345
    Best OA location URL: https://n.neurology.org/content/neurology/82/16/1465.full.pdf
    Citation Count: 18
  • Naltrexone for impulse control disorders in Parkinson disease
    2014
    Summary Details
    OPEN
    Title: Naltrexone for impulse control disorders in Parkinson disease
    Author(s): Kimberly Papay, Sharon X. Xie, Matthew Stern, Howard I. Hurtig, Andrew Siderowf, John E. Duda, James Minger, Daniel Weintraub
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 83
    Issue #: 9
    Start Page: 826
    End Page: 833
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000729
    Best OA location URL: https://n.neurology.org/content/neurology/83/9/826.full.pdf
    Citation Count: 95
  • Imaging prodromal Parkinson disease
    2014
    Summary Details
    OPEN
    Title: Imaging prodromal Parkinson disease
    Author(s): Danna Jennings, Andrew Siderowf, Matthew Stern, John Seibyl, Shirley Eberly, David Oakes, Kenneth Marek, For the PARS Investigators
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 83
    Issue #: 19
    Start Page: 1739
    End Page: 1746
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000960
    Best OA location URL: https://n.neurology.org/content/neurology/83/19/1739.full.pdf
    Citation Count: 169
  • Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging
    2015
    Summary Details
    OPEN
    Title: Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging
    Author(s): V. Shane Pankratz, Rosebud O. Roberts, Michelle M. Mielke, David S. Knopman, Clifford R. Jack, Yonas E. Geda, Walter A. Rocca, Ronald C. Petersen
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 84
    Issue #: 14
    Start Page: 1433
    End Page: 1442
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000001437
    Best OA location URL: https://n.neurology.org/content/neurology/84/14/1433.full.pdf
    Citation Count: 150
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.